For many people of a certain age, the DEC VAX was the first computer they ever used. They were everywhere, powerful for their day, and relatively affordable for schools and businesses. These ...

This study is evaluating the safety, tolerability and immunogenicity of VAX-24, the Company’s 24-valent pneumococcal conjugate vaccine (PCV) candidate designed to prevent invasive pneumococcal ...

Based on these findings, the Company has selected the VAX-24 Mid dose as the basis for advancement of an optimized dose formulation to a potential Phase 3 program and, pending the VAX-31 infant ...